According to Longboard Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -A$0.11 B. In 2023 the company made an earning of -A$85.14 M a decrease over its 2022 earnings that were of -A$67.2 M.The earnings displayed on this page is the company's Pretax Income.